Shouhou Zhou Selected Research

CVAD protocol

12/2014

Safe and effective dosing of basal-bolus insulin in patients receiving high-dose steroids for hyper-cyclophosphamide, doxorubicin, vincristine, and dexamethasone chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shouhou Zhou Research Topics

Disease

1	Hyperglycemia 12/2014
1	Leukemia 12/2014
1	Neoplasms (Cancer) 12/2014

Drug/Important Bio-Agent (IBA)

1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2014
1	Glucose (Dextrose)FDA LinkGeneric 12/2014
1	Insulin (Novolin)FDA Link 12/2014
1	SteroidsIBA 12/2014
1	Vincristine (Oncovin)FDA LinkGeneric 12/2014

Therapy/Procedure

1	CVAD protocol 12/2014
1	Drug Therapy (Chemotherapy) 12/2014
1	Therapeutics 12/2014